Hemant Surgical Industries Share Price

Hemant Surgical Industries Share Price

  • 381.0012.00 (3.25%)
BSE
  • Closed
  • As On: 10 Jun, 2026, 03:40 PM IST
Loading...
Open-
High-
Low-
Prev Close-
Volume-
VWAP(₹)-

Key Metrics

PE Ratio(x)-
EPS - TTM(₹)-
MCap(₹ Cr.)553.88
MCap Rank206
PB Ratio(x)3.91
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)446.00
52W Low(₹)91.00
MCap/Sales1.22
Beta(1 Month)-
BV/Share(₹)94.68

Hemant Surgical Ind share price insights

  • Beating 3 Yr Revenue CAGR

    Company's annual revenue growth of 112.04% outperformed its 3 year CAGR of 28.2%. (Source: Standalone Financials)
  • Employee & Interest Expense

    Company has spent 1.28% of its operating revenues towards interest expenses and 4.35% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Hemant Surgical Ind Share Price Update

    Hemant Surgical Industries Ltd. share price moved up by 3.25% from its previous close of Rs 369.00. Hemant Surgical Industries Ltd. stock last traded price is 381.00

    Share PriceValue
    Today/Current/Last381.00
    Previous Day369.00

Found Insights useful?

Hemant Surgical Ind Share Price Returns

1 Day3.25%
1 Month26.37%
3 Months47.1%
1 Year288.78%
3 Years128.62%
5 YearsN.A.

Hemant Surgical Ind Share Recommendations

No Recommendations details available for this stock.
Check out other stock recos.

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • AnnualFY 2026
    Total Revenue237.67
    Total Revenue Growth (%)112.67
    Total Expenses213.08
    Total Expenses Growth (%)110.37
    Profit after Tax (PAT)19.19
    PAT Growth (%)138.66
    Operating Profit Margin (%)11.88
    Net Profit Margin (%)8.27
    Basic EPS (₹)15.39
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue236.71111.64109.92111.50105.77
    Total Revenue Growth (%)112.041.57-1.425.4174.39
    Total Expenses213.08101.0897.13101.4499.66
    Total Expenses Growth (%)110.804.07-4.241.7968.54
    Profit after Tax (PAT)18.238.139.807.654.61
    PAT Growth (%)124.22-17.0228.0865.82302.86
    Operating Profit Margin (%)11.9411.9713.0210.967.48
    Net Profit Margin (%)7.897.639.277.004.45
    Basic EPS (₹)15.427.799.8510.288.96

    No Data Available

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Beating 3 Yr Revenue CAGR

      Company's annual revenue growth of 112.04% outperformed its 3 year CAGR of 28.2%. (Source: Standalone Financials)
    • Employee & Interest Expense

      Company has spent 1.28% of its operating revenues towards interest expenses and 4.35% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2026
    Total Assets274.26
    Total Assets Growth (%)84.93
    Total Liabilities136.62
    Total Liabilities Growth (%)60.47
    Total Equity137.64
    Total Equity Growth (%)117.88
    Current Ratio (x)1.45
    Total Debt to Equity (x)0.36
    Contingent Liabilities0.00
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets274.01147.6496.6464.9154.38
    Total Assets Growth (%)85.5952.7748.8819.3626.76
    Total Liabilities136.5084.6541.7841.3141.23
    Total Liabilities Growth (%)61.25102.611.140.1924.49
    Total Equity137.5062.9954.8623.6013.15
    Total Equity Growth (%)118.2914.82132.4679.4734.46
    Current Ratio (x)1.441.451.831.231.02
    Total Debt to Equity (x)0.360.490.120.300.74
    Contingent Liabilities0.006.778.755.775.17

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026
    Net Cash flow from Operating Activities-32.04
    Net Cash used in Investing Activities-2.97
    Net Cash flow from Financing Activities69.31
    Net Cash Flow34.29
    Closing Cash & Cash Equivalent43.84
    Closing Cash & Cash Equivalent Growth (%)359.17
    Total Debt/ CFO (x)-1.55
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities-32.028.92-7.568.6412.06
    Net Cash used in Investing Activities-2.97-30.28-8.97-1.60-0.05
    Net Cash flow from Financing Activities69.3717.6421.24-4.41-7.70
    Net Cash Flow34.37-3.714.712.634.31
    Closing Cash & Cash Equivalent43.839.4613.178.465.83
    Closing Cash & Cash Equivalent Growth (%)363.48-28.2055.7545.16284.16
    Total Debt/ CFO (x)-1.553.46-0.890.820.81

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Decrease in Cash from Investing

      Company has used Rs 2.97 cr for investing activities which is an YoY decrease of 90.17%. (Source: Standalone Financials)
  • AnnualFY 2026
    Return on Equity (%)13.94
    Return on Capital Employed (%)19.51
    Return on Assets (%)6.99
    Interest Coverage Ratio (x)9.81
    Asset Turnover Ratio (x)1.10
    Price to Earnings (x)14.79
    Price to Book (x)2.06
    EV/EBITDA (x)9.95
    EBITDA Margin (%)12.54
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)13.2612.9117.8632.4235.09
    Return on Capital Employed (%)19.5614.6823.3744.3744.51
    Return on Assets (%)6.655.5010.1411.788.48
    Interest Coverage Ratio (x)7.346.4315.216.705.19
    Asset Turnover Ratio (x)1.100.871.311.832.13
    Price to Earnings (x)15.5812.8014.20--
    Price to Book (x)2.061.652.53--
    EV/EBITDA (x)9.948.848.97--
    EBITDA Margin (%)12.6013.3113.9911.748.20

Found Financials useful?

Technicals

Peer Comparison

  • NAMEP/E (x)P/B (x)ROE %ROCE %ROA %Rev CAGR [3Yr]OPMNPMBasic EPSCurrent RatioTotal Debt/ Equity (x)Total Debt/ CFO (x)
    Hemant Surgical Ind0.004.0213.9419.516.9928.3711.888.2715.391.450.36-1.55
    Add More stocks of your interest to compare.
    Annual Ratios (%)

    Choose from Peers

      Choose from Stocks

        • CHART
        • TABLE
        • 1D
        • 1W
        • 1M
        • 3M
        • 6M
        • 1Y
        • 5Y
        • There’s no suggested peer for this stock.

      Shareholding Pattern

      • CategoryNo. of SharesPercentage% Change QoQ
        Promoters76,80,00058.90 %0.00
        Pledge00.00 %0.00
        FII20,0000.15 %0.00
        DII13,99,20010.73 %-0.08
        Others39,39,20030.22 %0.07
      • CategoryMar 2026Sep 2025Mar 2025
        Promoters58.9058.9073.56
        Pledge0.000.000.00
        FII0.150.150.39
        DII10.7310.811.11
        Mutual Funds0.000.000.00
        Others30.2230.1424.93

      Mutual Funds Ownership

      No Data Available

      Corporate Actions

      • Board Meeting

        Audited Results

        May 11, 2026

        Board Meeting

        Half Yearly Results

        Nov 06, 2025

        General Meeting

        -

        Aug 28, 2025

      • Announced onMeeting on
        May 11, 2026May 15, 2026
        Audited Results
        Nov 06, 2025Nov 12, 2025
        Half Yearly Results
        Aug 01, 2025Aug 06, 2025
        Preferential issue of shares
        May 16, 2025May 28, 2025
        Audited Results
        Nov 05, 2024Nov 13, 2024
        Half Yearly Results
      • No Data Available

      • No Data Available

      • No Data Available

      • No Data Available

      • Announced onMeeting on
        Aug 28, 2025Sep 23, 2025
        -
        Aug 11, 2025Aug 30, 2025
        -
        Aug 30, 2024Sep 25, 2024
        A.G.M.
        Aug 29, 2023Sep 30, 2023
        A.G.M.

      About Hemant Surgical Ind

      Industry

      Others

      Key Indices Listed On

      -

      Address

      502, 5th Floor,Ecstasy Business Park Co-Op Socteiy Limited,J.S.D. Road, Mulund West,Mumbai, Maharashtra - 400080

      Executive Leadership

      HS

      Hanskumar Shah

      Chairman & Managing Director
      KH

      Kaushik Hanskumar Shah

      WholeTime Director & CFO
      HP

      Hemant Praful Shah

      Whole Time Director
      NB

      Nehal Babu Karelia

      Non Executive Director
      Show More

      Auditors

      ADV & Associates

      FAQs about Hemant Surgical Ind share

      • 1. What's the Hemant Surgical Ind share price today?
        Hemant Surgical Ind share price is Rs 381.00 as on 10 Jun, 2026, 03:40 PM IST. Hemant Surgical Ind share price is up by 3.25% based on previous share price of Rs. 360.5.
      • 2. What is Hemant Surgical Ind's 52 week high / low?
        In last 52 weeks Hemant Surgical Ind share had a high price of Rs 446.00 and low price of Rs 91.00
      • 3. What are the returns for Hemant Surgical Ind share?
        Return Performance of Hemant Surgical Ind Shares:
        • 1 Week: Hemant Surgical Ind share price moved down by 0.29%
      • 4. What's the market capitalization of Hemant Surgical Ind?
        Within the General sector, Hemant Surgical Ind stock has a market cap rank of 206. Hemant Surgical Ind has a market cap of Rs 553.88 Cr.
      • 5. What is the PE & PB ratio of Hemant Surgical Ind?
        The PE ratio of Hemant Surgical Ind stands at null, while the PB ratio is 3.79.

      Top Gainers

      As on 03:59 PM | 10 Jun 2026
      Inox India
      1,891.60
      204.90 (12.15%)
      Akums Drugs & Pharma
      592.10
      43.86 (8.00%)
      Chambal Fertilisers
      477.65
      22.90 (5.04%)
      Afcons Infrastru
      330.05
      14.56 (4.62%)
      Concord Biotech Ltd.
      1,330.70
      58.50 (4.60%)

      Top Losers

      As on 03:59 PM | 10 Jun 2026
      Oil India Ltd
      427.35
      -48.60 (-10.22%)
      IFCI
      71.83
      -5.24 (-6.80%)
      Manappuram Finance
      288.25
      -19.00 (-6.19%)
      Jindal Saw
      225.16
      -14.66 (-6.11%)
      NLC India
      309.60
      -18.15 (-5.54%)

      DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

      DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

      By using this site, you agree to the Terms of Service and Privacy Policy.